References
- Ågren H, Wide L. Patterns of depression reflected in pituitary-thyroid and pituitary-adrenal endocrine changes. Psychoneuroendocrinology 1982; 7: 309–327
- Ågren H, Niklasson F, Hallgren R. Brain purinergic activity linked with depressive symptomatology: Hypoxanthine and xanthine in CSF of patients with major depressive disorders. Psychiatry Research 1983; 9: 179–190
- Ågren H, Lundqvist G. Low levels of somatostatin in human CSF mark depressive episodes. Psychoneuroendocrinology 1984; 9: 233–248
- Arimura A, Lundqvist G, Rothman J, Chang R, Fer-nandez-Durango R, Elde R, Coy D H, Meyers C, Schally A V. Radioimmunoassay of somatostatin. Metabolism 1978; 27: 1139–1144, (Suppl. 1)
- Berelowitz M, Perlow M J, Frohman L A. The effect of intravenous growth hormone infusion on cerebrospinal fluid somatostatin levels in the Rhesus monkey. Brain Research 1982; 241: 355–358
- Carroll B J, Feinberg M, Greden J F, Tarika J, Albala A A, Haskett R F, James N M, Kronfol Z, Lohr N, Steiner M, de Vigne J P, Young E. A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Archives of General Psychiatry 1981; 38: 15–22
- Dupont E, Christensen S E, Hansen A P, de Fine Olivarius B, Orskov H. Low cerebrospinal fluid somatostatin in Parkinson disease: An irreversible abnormality. Neurology (Ny) 1982; 32: 312–314
- Eckernas S A, Aquilonius S-M, Lundqvist G, Roos B-E. Regional distribution of cholinergic and monoaminergic markers, somatostatin and Substance P in the human brain. Acta Neurologica Scandina-vica Suppl. 67 1978; 57: 225–226
- Endicott J, Spitzer R L. Use of the Research Diagnostic Criteria and the Schedule of Affective Disorders and Schizophrenia to study affective disorders. American Journal of Psychiatry 1979; 136: 52–56
- Endicott J, Cohen J, Fleiss J, Sarantakos S. Hamilton depression rating scale: extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 1981; 38: 98–103
- Gerner R H, Yamada T. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Research 1982; 238: 298–302
- Lundqvist G, Gustavsson S, Elde R, Arimura A. A radioimmunoabsorbent assay for plasma somatostatin. Clinica Chimica Acta 1980; 101: 183–191
- Mc Cann S M. Physiology and pharmacology of LHRH and somatostatin. Annual Revue of Pharmacology and Toxicology 1982; 22: 491–515
- Post R M, Gold P W, Rubinow D R, Ballenger J C, Bunney W EJR, Goodwin F K. Peptides in the cerebrospinal fluid of neuropsychiatric patients: An approach to central nervous system peptide function. Life Sciences 1982; 31: 1–15
- Rubinow D R, Gold P W, Post R M, Ballenger J C, Cowdry R, Bollinger J, Reichlin S. CSF somatostatin in affective illness. Archives of General Psychiatry 1983; 40: 409–412
- Sørensen K V, Christensen S E, Dupont E, Hansen A P, Pedersen E, Orskov H. Low somatostatin content in cerebrospinal fluid in multiple sclerosis. Acta Neurologica Scandinavica 1980; 61: 186–191
- Sørensen K V, Christensen S E, Hansen A P, Ingerslev J, Pedersen E, Orskov H. The origin of cerebrospinal fluid somatostatin: Hypothalamic or disperse central nervous system secretion?. Neuroen-docrinology 1981; 32: 335–338
- Sørensen K V. Somatostatin: Localization and distribution in the cortex and the subcortical white matter of human brain. Neuroscience 1982; 7: 1227–1232
- Stine S M, Yang H-Y, Costa E. Evidence for ascending and descending intraspinal as well as primary sensory somatostatin projections in the rat spinal cord. Journal of Neurochemistry 1982; 38: 1144–1150
- Vale W, Brazeau P, Rivier C, Brown M, Boss B, Rivier J, Burgus R, Ling N, Guillemin R. Somatostatin. Recent Progress in Hormone Research 1975; 34: 365–397
- Wood P L, Etienne P, Lai S, Gauthier S, Cajal S, Nair N PV. Reduced lumbar CSF somatostatin in Alzheimer's disease. Life Sciences 1982; 31: 2073–2079